Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STEPHEN M MULROONEY

NPI
1700880168
CMS profile
350169
Location
NEW YORK, NY

General Payments · PY2020–2024

$1,021.56

  • Reported across 42 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,002.55

41 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,002.55 41

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $19.01 1
PY2024 $1,002.55 41

Payment records · PY2024 (41)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.44 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105081109 CMS
ABBVIE INC. $33.63 07/23/2024 Food and Beverage Undisputed 01/23/2026 1105081111 CMS
ABBVIE INC. $28.71 08/14/2024 Food and Beverage Undisputed 01/23/2026 1105081113 CMS
ABBVIE INC. $17.03 10/08/2024 Food and Beverage Undisputed 01/23/2026 1105081115 CMS
ABBVIE INC. $1.79 10/08/2024 Food and Beverage Undisputed 01/23/2026 1105081117 CMS
ABBVIE INC. $27.96 10/15/2024 Food and Beverage Undisputed 01/23/2026 1105081119 CMS
ABBVIE INC. $19.29 10/21/2024 Food and Beverage Undisputed 01/23/2026 1105081121 CMS
ABBVIE INC. $1.14 10/22/2024 Food and Beverage Undisputed 01/23/2026 1105081123 CMS
ABBVIE INC. $22.91 12/11/2024 Food and Beverage Undisputed 01/23/2026 1105081125 CMS
ABBVIE INC. $1.01 12/11/2024 Food and Beverage Undisputed 01/23/2026 1105081127 CMS
ABBVIE INC. $29.44 12/12/2024 Food and Beverage Undisputed 01/23/2026 1105081129 CMS
ABBVIE INC. $3.58 12/12/2024 Food and Beverage Undisputed 01/23/2026 1105081131 CMS
AIMMUNE THERAPEUTICS, INC. $23.22 12/18/2024 Food and Beverage Undisputed 01/23/2026 1147011066 CMS
Ardelyx, Inc. $23.20 09/30/2024 Food and Beverage Undisputed 01/23/2026 1146696876 CMS
Ardelyx, Inc. $16.44 11/03/2024 Food and Beverage Undisputed 01/23/2026 1146696878 CMS
Celgene Corporation $21.29 09/09/2024 Food and Beverage Undisputed 01/23/2026 1101122470 CMS
Celgene Corporation $16.81 09/24/2024 Food and Beverage Undisputed 01/23/2026 1101122474 CMS
Celgene Corporation $17.47 10/16/2024 Food and Beverage Undisputed 01/23/2026 1101122476 CMS
Enterra Medical, Inc. $28.02 11/19/2024 Food and Beverage Undisputed 01/23/2026 1154809722 CMS
EVOKE PHARMA, INC. $14.14 11/06/2024 Food and Beverage Undisputed 01/23/2026 1127779467 CMS
EVOKE PHARMA, INC. $220.30 11/06/2024 Food and Beverage Undisputed 01/23/2026 1127779469 CMS
GENZYME CORPORATION $32.24 04/15/2024 Food and Beverage Undisputed 01/23/2026 1139983376 CMS
Janssen Biotech, Inc. $19.94 03/19/2024 Food and Beverage Undisputed 01/23/2026 1078456821 CMS
Janssen Biotech, Inc. $25.22 06/11/2024 Food and Beverage Undisputed 01/23/2026 1078458769 CMS
Janssen Biotech, Inc. $17.93 11/04/2024 Food and Beverage Undisputed 01/23/2026 1078447623 CMS
Novo Nordisk Inc $22.64 03/18/2024 Food and Beverage Undisputed 01/23/2026 1096597326 CMS
Novo Nordisk Inc $13.78 05/07/2024 Food and Beverage Undisputed 01/23/2026 1097071203 CMS
Novo Nordisk Inc $17.27 07/18/2024 Food and Beverage Undisputed 01/23/2026 1096704141 CMS
Novo Nordisk Inc $16.03 09/18/2024 Food and Beverage Undisputed 01/23/2026 1096622504 CMS
Novo Nordisk Inc $17.30 10/09/2024 Food and Beverage Undisputed 01/23/2026 1096778608 CMS
Novo Nordisk Inc $22.15 10/21/2024 Food and Beverage Undisputed 01/23/2026 1097485868 CMS
Phathom Pharmaceuticals, Inc. $24.18 02/15/2024 Food and Beverage Undisputed 01/23/2026 1151099499 CMS
Phathom Pharmaceuticals, Inc. $28.83 04/10/2024 Food and Beverage Undisputed 01/23/2026 1151099501 CMS
Phathom Pharmaceuticals, Inc. $1.06 06/04/2024 Food and Beverage Undisputed 01/23/2026 1151099503 CMS
Phathom Pharmaceuticals, Inc. $25.65 06/04/2024 Food and Beverage Undisputed 01/23/2026 1151099505 CMS
Phathom Pharmaceuticals, Inc. $28.39 07/16/2024 Food and Beverage Undisputed 01/23/2026 1151099507 CMS
Phathom Pharmaceuticals, Inc. $29.76 07/31/2024 Food and Beverage Undisputed 01/23/2026 1151099509 CMS
Phathom Pharmaceuticals, Inc. $24.78 08/27/2024 Food and Beverage Undisputed 01/23/2026 1151099511 CMS
Phathom Pharmaceuticals, Inc. $18.85 09/11/2024 Food and Beverage Undisputed 01/23/2026 1151099513 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.13 07/17/2024 Food and Beverage Undisputed 01/23/2026 1137639588 CMS
VIVUS LLC $16.60 11/11/2024 Food and Beverage Undisputed 01/23/2026 1129417213 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.